Works matching IS 25094254 AND DT 2023 AND VI 7 AND IP 4

Results: 13

Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 665, doi. 10.1007/s41669-023-00417-y

By:

Kristensen, Anders E.;
Kurman, Jonathan S.;
Hogarth, D. K.;
Sethi, Sonali;
Sørensen, Sabrina S.

Publication type:

Article

Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 537, doi. 10.1007/s41669-023-00418-x

By:

Shah, Hiral Anil;
Baker, Tim;
Schell, Carl Otto;
Kuwawenaruwa, August;
Awadh, Khamis;
Khalid, Karima;
Kairu, Angela;
Were, Vincent;
Barasa, Edwine;
Baker, Peter;
Guinness, Lorna

Publication type:

Article

Cost-Effectiveness of Semaglutide vs. Empagliflozin, Canagliflozin, and Sitagliptin for Treatment of Patients with Type 2 Diabetes in Denmark: A Decision-Analytic Modelling Study.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 579, doi. 10.1007/s41669-023-00416-z

By:

Pulleyblank, Ryan;
Larsen, Nikolaj Birk

Publication type:

Article

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 507, doi. 10.1007/s41669-023-00414-1

By:

Lin, Yi-Shu;
O'Mahony, James F;
van Rosmalen, Joost

Publication type:

Article

Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 593, doi. 10.1007/s41669-023-00413-2

By:

Koster, Fiona;
Kok, Marc R.;
van der Kooij, Jaco;
Waverijn, Geeke;
Weel-Koenders, Angelique E. A. M.;
Barreto, Deirisa Lopes

Publication type:

Article

Effect of Perioperative Oral Vitamin C Supplementation on In-Hospital Postoperative Medication Costs for Cardiac Surgery Patients: A Prospective, Single-Centre, Randomised Clinical Trial.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 655, doi. 10.1007/s41669-023-00412-3

By:

Heerman, Jan;
Boydens, Charlotte;
Allaert, Silvie;
Cathenis, Koen;
Deryckere, Koen;
Vanoverschelde, Henk

Publication type:

Article

Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 639, doi. 10.1007/s41669-023-00411-4

By:

Caillon, Megane;
Brethon, Benoit;
van Beurden-Tan, Chrissy;
Supiot, Romain;
Le Mezo, Antoine;
Chauny, Jean-Vannak;
Majer, Istvan;
Petit, Arnaud

Publication type:

Article

Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 525, doi. 10.1007/s41669-023-00408-z

By:

Bresnahan, Rebecca;
Houten, Rachel;
Greenhalgh, Janette;
Nevitt, Sarah;
Mahon, James;
Beale, Sophie;
Boland, Angela;
Bhattacharyya, Devarshi;
Dundar, Yenal;
McEntee, Joanne;
Gandhi, Shreyans;
Fleeman, Nigel;
Chaplin, Marty

Publication type:

Article

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 617, doi. 10.1007/s41669-023-00407-0

By:

Vanderpoel, Julie;
Emond, Bruno;
Ghelerter, Isabelle;
Milbers, Katherine;
Lafeuille, Marie-Hélène;
Lefebvre, Patrick;
Ellis, Lorie A.

Publication type:

Article

Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 553, doi. 10.1007/s41669-023-00406-1

By:

Mills, Mackenzie;
Kanavos, Panos

Publication type:

Article

Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 605, doi. 10.1007/s41669-023-00401-6

By:

Wahono, Cesarius Singgih;
Hamijoyo, Laniyati;
Hendrawan, Yuriawati;
Rakinaturia, Liyana;
Mittal, Neha;
Khanna, Prabal;
Jain, Minal;
Isbagio, Harry

Publication type:

Article

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 627, doi. 10.1007/s41669-023-00397-z

By:

Kruger, Eliza;
Aggio, Daniel;
de Freitas, Hayley;
Lloyd, Andrew

Publication type:

Article

Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 4, p. 567, doi. 10.1007/s41669-023-00395-1

By:

Çakar, Esra;
Oniangue-Ndza, César;
Schneider, Ralph P.;
Klijn, Sven L.;
Vogl, Ursula M.;
Rothermundt, Christian;
May, Jessica R.

Publication type:

Article